San Francisco Sun

16 San Francisco biopharma companies could be negatively impacted by Inflation Reduction Act drug provision

By San Francisco Sun News Service | Apr 22, 2024

A provision of the “Inflation Reduction Act” (IRA) could threaten investments in "small molecule" drug development, said the head of the Pasadena-based Pacific Research Institute (PRI).